4 participants
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-09
- Start Date:
- 2021-11-10
- Completion:
- 2022-03-16
Conditions
- Type 2 Diabetes
- Glucose Tolerance Impaired
- Insulin Sensitivity
Interventions
- DRUG
No Results Yet